New imaging agent could light up rare tumors
Knowledge-focused
Recruiting now
This early-phase study is testing an investigational radioactive tracer called 18F-FluorThanatrace (FTT) for PET/CT scans in up to 30 people with pheochromocytoma or paraganglioma—rare tumors of the adrenal glands or nerve tissue. The tracer aims to measure a protein called PARP-…
Phase: EARLY_PHASE1 • Sponsor: Heather Wachtel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC